Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin in Youth with ASD
NCT05934812Phase 2Not yet recruiting
- Sponsor
- Oslo University Hospital
- Start
- Sep 2024
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD), sponsored by Oslo University Hospital. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05934812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05934812.